Clinical trial
Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women
NCT00326716 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00326716 |
|---|---|
| Title | Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women |
| Official title | A Study of the Pharmacokinetics of Atazanavir (ATV)/Ritonavir(RTV) Administered as Part of Highly Active Antiretroviral Therapy (HAART) in HIV-1 Infected Pregnant Women |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Atazanavir + Ritonavir + Combivir |
| Enrollment | 69 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 17, 2006 |
| Last update posted | Nov 16, 2011 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: